研究文章
血清中性粒细胞Gelatinase-Associated Lipocalin (NGAL) HCV-Positive埃及Sofosbuvir患者
|
| 参数 |
(没有。,%) |
血清NGAL (ng / ml) |
价值 |
|
| 性别 |
|
|
|
| 男性 |
26 (29.9%) |
336.69±217.31 |
0.75 |
| 女 |
61例(70.1%) |
330.92±333.69 |
|
| 糖尿病 |
|
|
|
| 是的 |
6 (6.9%) |
265.73±60.40 |
0.39 |
| 没有 |
81例(93.1%) |
337.60±312.55 |
|
| 高血压 |
|
|
|
| 是的 |
18 (20.7%) |
362.4±279.77 |
0.35 |
| 没有 |
69例(79.3%) |
324.88±309.44 |
|
| 肝 |
|
|
|
| 正常的 |
60 (69%) |
327.19±221.00 |
0.65 |
| 肝硬化 |
27 (31%) |
344.78±437.42 |
|
| 丙肝病毒核糖核酸(拷贝/毫升) |
|
|
|
| 不到1000000 |
51 (58.6%) |
336.57±356.83 |
0.58 |
| 超过1000000 |
36 (41.4%) |
327.09±206.59 |
|
| FIB4 |
|
|
|
| G1: < 1.45 |
41 (47.1%) |
329.99±368.24 |
|
| G2: 1.45至3.25 |
42 (38。3%) |
346.56±240.549 |
|
| G3: > 3.25 |
4 (4.6%) |
213.8±15.05 |
|
|
| APRI |
|
|
|
| G1: < 0.5 |
45 (51.7%) |
329.99±368.24 |
|
| G2: 0.5 - -1.5 |
38 (43.7%) |
346.56±240.55 |
|
| G3: > 1.5 |
4 (4.6%) |
213.8±15.05 |
|
|
|
G:集团;
:
G1和G2的价值;
:
G1 vs G3价值;
:
G2和G3的价值。
|
